Sio Gene Therapies Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2PO
- Latest Deal Amount
-
$40M
Sio Gene Therapies General Information
Description
Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis.
Contact Information
Website
www.siogtx.comCorporate Office
- 130 West 42nd Street
- 26th floor
- New York, NY 10036
- United States
Corporate Office
- 130 West 42nd Street
- 26th floor
- New York, NY 10036
- United States
Sio Gene Therapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. 2PO | 15-Mar-2019 | $40M | Completed | Clinical Trials - Phase 3 | ||
| 4. 2PO | 17-Dec-2018 | Completed | Clinical Trials - Phase 3 | |||
| 3. Debt - General | 02-Feb-2017 | Completed | Clinical Trials - Phase 3 | |||
| 2. IPO | 11-Jun-2015 | $315M | $315M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC | Completed | Startup |
Sio Gene Therapies Comparisons
Industry
Financing
Details
Sio Gene Therapies Competitors (11)
One of Sio Gene Therapies’s 11 competitors is Catalyst Pharmaceuticals, a Corporate Backed or Acquired company based in Coral Gables, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Catalyst Pharmaceuticals | Corporate Backed or Acquired | Coral Gables, FL | ||||
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Moderna | Formerly VC-backed | Cambridge, MA | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Scynexis | Formerly VC-backed | Jersey City, NJ |
Sio Gene Therapies Patents
Sio Gene Therapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023004365-A1 | Vector constructs for delivery of nucleic acids encoding therapeutic proteasome activator complex subunits and methods of using the same | Inactive | 20-Jul-2021 | ||
| EP-3937985-A1 | Gene therapy compositions and methods for treating parkinson's disease | Inactive | 10-Mar-2019 | ||
| US-20220175962-A1 | Gene therapy compositions and methods for treating parkinson's disease | Inactive | 10-Mar-2019 | ||
| WO-2020183374-A1 | Gene therapy compositions and methods for treating parkinson's disease | Inactive | 10-Mar-2019 | ||
| US-20190046506-A1 | Use of 5ht2a inverse agonists for treating psychosis | Inactive | 10-Aug-2017 | A61K31/415 |
Sio Gene Therapies Signals
Sio Gene Therapies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Sio Gene Therapies FAQs
-
When was Sio Gene Therapies founded?
Sio Gene Therapies was founded in 2014.
-
Where is Sio Gene Therapies headquartered?
Sio Gene Therapies is headquartered in New York, NY.
-
What is the size of Sio Gene Therapies?
Sio Gene Therapies has 12 total employees.
-
What industry is Sio Gene Therapies in?
Sio Gene Therapies’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Sio Gene Therapies a private or public company?
Sio Gene Therapies is a Private company.
-
What is Sio Gene Therapies’s current revenue?
The current revenue for Sio Gene Therapies is .
-
How much funding has Sio Gene Therapies raised over time?
Sio Gene Therapies has raised $440M.
-
Who are Sio Gene Therapies’s competitors?
Catalyst Pharmaceuticals, ACADIA Pharmaceuticals, Moderna, Alnylam Pharmaceuticals, and Scynexis are some of the 11 competitors of Sio Gene Therapies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process